Literature DB >> 11399775

Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton.

I Tan1, C H Ng, L Lim, T Leung.   

Abstract

The myotonic dystrophy kinase-related kinases RhoA binding kinase and myotonic dystrophy kinase-related Cdc42 binding kinase (MRCK) are effectors of RhoA and Cdc42, respectively, for actin reorganization. Using substrate screening in various tissues, we uncovered two major substrates, p130 and p85, for MRCKalpha-kinase. p130 is identified as myosin binding subunit p130, whereas p85 is a novel related protein. p85 contains N-terminal ankyrin repeats, an alpha-helical C terminus with leucine repeats, and a centrally located conserved motif with the MRCKalpha-kinase phosphorylation site. Like MBS130, p85 is specifically associated with protein phosphatase 1delta (PP1delta), and this requires the N terminus, including the ankyrin repeats. This association is required for the regulation of both the catalytic activities and the assembly of actin cytoskeleton. The N terminus, in association with PP1delta, is essential for actin depolymerization, whereas the C terminus antagonizes this action. The C-terminal effects consist of two independent events that involved both the conserved phosphorylation inhibitory motif and the alpha-helical leucine repeats. The former was able to interact with PP1delta only in the phosphorylated state and result in inactivation of PP1delta activity. This provides further evidence that phosphorylation of a myosin binding subunit protein by specific kinases confers conformational changes in a highly conserved region that plays an essential role in the regulation of its catalytic subunit activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399775     DOI: 10.1074/jbc.M102615200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  The ankyrin repeat as molecular architecture for protein recognition.

Authors:  Leila K Mosavi; Tobin J Cammett; Daniel C Desrosiers; Zheng-Yu Peng
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

2.  p116Rip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis.

Authors:  Jacqueline Mulder; Aafke Ariaens; Dick van den Boomen; Wouter H Moolenaar
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

Review 3.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

4.  The cytoskeletal regulator Genghis khan is required for columnar target specificity in the Drosophila visual system.

Authors:  Allison C Gontang; Jennifer J Hwa; Joshua D Mast; Tina Schwabe; Thomas R Clandinin
Journal:  Development       Date:  2011-10-17       Impact factor: 6.868

5.  Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.

Authors:  Russell C DeKelver; Vivian M Choi; Erica A Moehle; David E Paschon; Dirk Hockemeyer; Sebastiaan H Meijsing; Yasemin Sancak; Xiaoxia Cui; Eveline J Steine; Jeffrey C Miller; Phillip Tam; Victor V Bartsevich; Xiangdong Meng; Igor Rupniewski; Sunita M Gopalan; Helena C Sun; Kathleen J Pitz; Jeremy M Rock; Lei Zhang; Gregory D Davis; Edward J Rebar; Iain M Cheeseman; Keith R Yamamoto; David M Sabatini; Rudolf Jaenisch; Philip D Gregory; Fyodor D Urnov
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

6.  Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.

Authors:  Kang Le; Chun-Chun Li; Guan Ye; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

7.  TIMAP is a positive regulator of pulmonary endothelial barrier function.

Authors:  Csilla Csortos; Istvan Czikora; Natalia V Bogatcheva; Djanybek M Adyshev; Christophe Poirier; Gabor Olah; Alexander D Verin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-06-27       Impact factor: 5.464

Review 8.  Gene therapy using adeno-associated virus vectors.

Authors:  Shyam Daya; Kenneth I Berns
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Adeno-associated virus site-specific integration and AAVS1 disruption.

Authors:  Henry Hamilton; Janette Gomos; Kenneth I Berns; Erik Falck-Pedersen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Stimulation of homology-directed gene targeting at an endogenous human locus by a nicking endonuclease.

Authors:  Gijsbert P van Nierop; Antoine A F de Vries; Maarten Holkers; Krijn R Vrijsen; Manuel A F V Gonçalves
Journal:  Nucleic Acids Res       Date:  2009-08-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.